BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2533698)

  • 1. How to improve adjuvant treatment results in postmenopausal patients.
    Mouridsen HT
    Recent Results Cancer Res; 1989; 115():144-52. PubMed ID: 2533698
    [No Abstract]   [Full Text] [Related]  

  • 2. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients. A randomized trial.
    Viladiu P; Alonso MC; Avella A; Beltrán M; Borrás J; Ojeda B; Bosch FX
    Cancer; 1985 Dec; 56(12):2745-50. PubMed ID: 3902200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
    Goldhirsch A; Castiglione M; Gelber RD
    Lancet; 1990 May; 335(8697):1099-100. PubMed ID: 1970400
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
    Pannuti F; Martoni A; Cilenti G; Camaggi CM; Fruet F
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):423-9. PubMed ID: 2968262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
    Rossi A; Brambilla C; Valagussa P; Bonadonna G
    Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
    [No Abstract]   [Full Text] [Related]  

  • 9. Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.
    Jakesz R; Reiner G; Schemper M; Reiner A; Blijham G; Rainer H; Dittrich D; Spona J; Schutte B; Reynders M
    Recent Results Cancer Res; 1989; 115():180-5. PubMed ID: 2696031
    [No Abstract]   [Full Text] [Related]  

  • 10. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
    Brambilla C; Rossi A; Valagussa P; Bonadonna G
    World J Surg; 1985 Oct; 9(5):728-37. PubMed ID: 3840630
    [No Abstract]   [Full Text] [Related]  

  • 12. Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
    Pearson OH; Hubay CA; Gordon NH; Marshall JS; Crowe JP; Arafah BM; McGuire W
    Cancer; 1989 Nov; 64(9):1819-23. PubMed ID: 2790695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone receptors. An update and application.
    Hubay CA; Arafah B; Gordon NH; Guyton SP; Crowe JP
    Surg Clin North Am; 1984 Dec; 64(6):1155-72. PubMed ID: 6393400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
    Tormey DC; Gray R; Gilchrist K; Grage T; Carbone PP; Wolter J; Woll JE; Cummings FJ
    Cancer; 1990 Jan; 65(2):200-6. PubMed ID: 2403834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemotherapy in primarily inoperable cancer of the breast.
    Luboinski G; Nagadowska M; Pienkowski T
    Eur J Surg Oncol; 1991 Dec; 17(6):603-7. PubMed ID: 1743309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
    Tormey DC
    Recent Results Cancer Res; 1989; 115():106-12. PubMed ID: 2623329
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant therapy in breast cancer.
    Dorr A
    Curr Opin Oncol; 1990 Dec; 2(6):1049-52. PubMed ID: 2099836
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
    Kaufmann M; Jonat W; Abel U
    Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
    Jonat W; Kaufmann M; Abel U
    Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.